DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Heartland Advisors Inc.

Key Points

• Heartland Advisors Inc. has increased its stake in DENTSPLY SIRONA by 31.1%, now owning 933,850 shares valued at approximately $13.95 million.
• DENTSPLY SIRONA reported earnings per share of $0.43 for the last quarter, surpassing analysts' expectations, but revenue fell 7.8% year-over-year.
• The company recently declared a quarterly dividend of $0.16, representing an annualized yield of 3.89%, though its dividend payout ratio is currently -14.10%.

Heartland Advisors Inc. boosted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 31.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 933,850 shares of the medical instruments supplier's stock after acquiring an additional 221,450 shares during the quarter. Heartland Advisors Inc. owned about 0.47% of DENTSPLY SIRONA worth $13,952,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $25,000. Colonial Trust Co SC bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after acquiring an additional 1,568 shares in the last quarter. True Wealth Design LLC lifted its stake in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares during the last quarter. Finally, Allworth Financial LP grew its position in shares of DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock worth $54,000 after buying an additional 2,517 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on XRAY shares. Piper Sandler decreased their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a report on Tuesday, April 15th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Finally, Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Ten analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus target price of $19.60.

DENTSPLY SIRONA Price Performance

XRAY stock traded down $0.02 during midday trading on Tuesday, hitting $16.05. 862,312 shares of the stock were exchanged, compared to its average volume of 2,829,382. The stock's 50-day moving average price is $16.03 and its 200-day moving average price is $16.16. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The stock has a market cap of $3.20 billion, a price-to-earnings ratio of -3.54, a PEG ratio of 1.14 and a beta of 0.94. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. DENTSPLY SIRONA's revenue was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.42 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.99%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.